Cargando…

Cognitive Reserve Assessment Scale in Health (CRASH): Its Validity and Reliability

(1) Background: The cognitive reserve (CR) concept has not been precisely defined in severe mental disorders and has been estimated using heterogeneous methods. This study aims to investigate and develop the psychometric properties of the Cognitive Reserve Assessment Scale in Health (CRASH), an inst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amoretti, Silvia, Cabrera, Bibiana, Torrent, Carla, Bonnín, Caterina del Mar, Mezquida, Gisela, Garriga, Marina, Jiménez, Esther, Martínez-Arán, Anabel, Solé, Brisa, Reinares, Maria, Varo, Cristina, Penadés, Rafael, Grande, Iria, Salagre, Estela, Parellada, Eduard, Bioque, Miquel, Garcia-Rizo, Clemente, Meseguer, Ana, Anmella, Gerard, Rosa, Adriane R, Contreras, Fernando, Safont, Gemma, Vieta, Eduard, Bernardo, Miquel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572583/ https://www.ncbi.nlm.nih.gov/pubmed/31035381 http://dx.doi.org/10.3390/jcm8050586

Ejemplares similares

M60. EARLY VERSUS DELAYED PRESCRIPTION OF CLOZAPINE AND THE COGNITIVE PERFORMANCE ON SCHIZOPHRENIA
por: Amoretti, Silvia, et al.
Publicado: (2020)

Effects of the COVID-19 pandemic and lockdown in Spain: comparison between community controls and patients with a psychiatric disorder. Preliminary results from the BRIS-MHC STUDY.
por: Solé, Brisa, et al.
Publicado: (2021)

Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study
por: Bioque, Miquel, et al.
Publicado: (2020)

Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies
por: Solé, Brisa, et al.
Publicado: (2017)

The search for new biomarkers for cognition in schizophrenia
por: Penadés, Rafael, et al.
Publicado: (2015)

Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability – a review
por: González-Rodríguez, Alexandre, et al.
Publicado: (2015)

F245. COGNITIVE RESERVE DIFFERENCE IN AFFECTIVE AND NONAFFECTIVE PSYCHOSIS
por: Amoretti, Silvia, et al.
Publicado: (2018)

Lifetime Psychotic Symptoms, Subthreshold Depression and Cognitive Impairment as Barriers to Functional Recovery in Patients with Bipolar Disorder
por: Bonnín, Caterina Mar, et al.
Publicado: (2019)

Toward Precision Psychiatry in Bipolar Disorder: Staging 2.0
por: Salagre, Estela, et al.
Publicado: (2018)

Self-reported neurocognitive symptoms during COVID-19 lockdown and its associated factors in a sample of psychiatric patients. Results from the BRIS-MHC study
por: Montejo, Laura, et al.
Publicado: (2021)

Functional Remediation for Bipolar Disorder
por: Martínez-Arán, Anabel, et al.
Publicado: (2011)

The role of genetics in cognitive remediation in schizophrenia: A systematic review
por: Penadés, Rafael, et al.
Publicado: (2019)

Resilience and mental health during the COVID-19 pandemic
por: Verdolini, Norma, et al.
Publicado: (2021)

S47. A MULTICENTER STUDY OF COGNITIVE RESERVE IN FIRST-EPISODE PYCHOSIS
por: Amoretti, Silvia, et al.
Publicado: (2020)

S229. THE EFFECT OF FAMILY ENVIRONMENT ON LONGITUDINAL FUNCTIONING IN FIRST PSYCHOTIC EPISODES
por: Verdolini, Norma, et al.
Publicado: (2020)

Exploring Risk and Resilient Profiles for Functional Impairment and Baseline Predictors in a 2-Year Follow-Up First-Episode Psychosis Cohort Using Latent Class Growth Analysis
por: Salagre, Estela, et al.
Publicado: (2020)

Emotional intelligence: a comparison between patients after first episode mania and those suffering from chronic bipolar disorder type I
por: Varo, Cristina, et al.
Publicado: (2023)

Cognitive Remediation Interventions in Schizoaffective Disorder: A Systematic Review
por: Lopez-Fernandez, Ester, et al.
Publicado: (2018)

Improving Functioning, Quality of Life, and Well-being in Patients With Bipolar Disorder
por: Bonnín, Caterina del Mar, et al.
Publicado: (2019)

The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a systematic review and meta-analysis of cerebrospinal fluid studies
por: Inam, Mehmet Enes, et al.
Publicado: (2023)

Biological rhythm disturbance in remitted bipolar patients
por: Rosa, Adriane R, et al.
Publicado: (2013)

The effect of early life events on glucose levels in first-episode psychosis
por: Garcia-Rizo, Clemente, et al.
Publicado: (2022)

F12. INFLAMMATORY BIOMARKERS AND COGNITION IN FIRST EPISODE PSYCHOSIS: GENDER DIFFERENCES
por: Llorca, Bibiana Cabrera, et al.
Publicado: (2018)

Physical health in affective disorders: a narrative review of the literature
por: Colomer, Lluc, et al.
Publicado: (2020)

Efficacy of an integrative approach for bipolar disorder: preliminary results from a randomized controlled trial
por: Valls, Èlia, et al.
Publicado: (2022)

A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project
por: Bioque, Miquel, et al.
Publicado: (2015)

Changing trends in psychiatric emergency service admissions during the COVID-19 outbreak: Report from a worldwide epicentre
por: Gómez-Ramiro, Marta, et al.
Publicado: (2021)

Genetic Variations Associated with Long-Term Treatment Response in Bipolar Depression
por: Anmella, Gerard, et al.
Publicado: (2021)

Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode
por: Segura, Alex G., et al.
Publicado: (2023)

Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder
por: Rosa, Adriane R, et al.
Publicado: (2007)

Exploring Digital Biomarkers of Illness Activity in Mood Episodes: Hypotheses Generating and Model Development Study
por: Anmella, Gerard, et al.
Publicado: (2023)

Corrigendum to “Effects of the COVID-19 pandemic and lockdown in Spain: Comparison between community controls and patients with a psychiatric disorder. Preliminary results from the BRIS-MHC STUDY” [J. Affect Disord. 2021 Feb 15; 281:13–23]
por: Solé, B., et al.
Publicado: (2023)

Protocol for the management of psychiatric patients with psychomotor agitation
por: Vieta, Eduard, et al.
Publicado: (2017)

Study Protocol—Coping With the Pandemics: What Works Best to Reduce Anxiety and Depressive Symptoms
por: Fortea, Lydia, et al.
Publicado: (2021)

Prodromal phase: Differences in prodromal symptoms, risk factors and markers of vulnerability in first episode mania versus first episode psychosis with onset in late adolescence or adulthood
por: Verdolini, Norma, et al.
Publicado: (2022)

Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients
por: Torrent, Carla, et al.
Publicado: (2010)

Electroconvulsive therapy following incident bipolar disorder: When, how, and for whom?
por: Salagre, Estela, et al.
Publicado: (2022)

A psychiatrist's perspective from a COVID-19 epicentre: a personal account
por: Pacchiarotti, Isabella, et al.
Publicado: (2020)

Risk Calculators in Bipolar Disorder: A Systematic Review
por: Silva Ribeiro, Joana, et al.
Publicado: (2020)

Electroconvulsive therapy protocol adaptation during the COVID-19 pandemic
por: Gil-Badenes, Joaquín, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2115p7quf60ifraqn2mkest9gt